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Reply to the Editor:
We thank Drs Khandani and Detterbeck for
their insightful comments on our article. Its
main conclusion was that standard uptake
values (SUVs) obtained from positron emis-
sion tomographic (PET) imaging were not
useful for staging lung cancers smaller than
2 cm. We note that there was no disagree-
ment with that conclusion, but rather the
suggestion that visual inspection by experi-
enced readers is now the accepted standard.
A listing of some of the technical reasons
why SUVs can be misleading is then given.
We agree that several recent articles
have suggested that an expert reading may
be equivalent to or better than a single cutoff
for SUV. However, this is by no means a
generally accepted standard. In fact, clini-
cians overwhelmingly continue to use the
maximum SUV for differentiating benign
from malignant lesions. This clinical prac-
tice is influenced by early PET reports,1 in
which a remarkably high accuracy of SUV
was reported for differentiating benign
from malignant nodules.
The problems outlined by Drs Khandani
and Detterbeck regarding the limitations of
the maximum SUV also affect the capabil-
ity of experienced clinicians in making
evaluations. Ultimately, anything that lim-
its the ability to make quantitative assess-
ments will also affect semiquantitative or
nonquantitative assessments as well. The
latest efforts in PET imaging include add-
ing some form of gating to improve quan-
titative assessments, and likely there will
again be discussion of whether this will
become the new accepted standard. For
now, the maximum SUV continues to be
reported and to guide clinical practice. We
look forward to improvements in PET tech-
nology and remain hopeful that the utility
of PET for small lesions will improve;
however, there are some fundamental lim-
itations that we believe will continue to be
problematic in the foreseeable future.
Jeffrey L. Port, MD
David F. Yankelevitz, MD
Nasser K. Altorki, MD
Department of Cardiothoracic Surgery
Weill Medical College of Cornell University
New York, NY
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Pulmonary lobectomy for cancer in
patients with chronic obstructive
pulmonary disease
To the Editor:
We have read with interest the report from
Baldi and colleagues1 reporting their expe-
rience with pulmonary lobectomy for lung
cancer in patients with chronic obstructive
pulmonary disease (COPD).1 On the basis
of their retrospective evaluation of 137 pa-
tients, they concluded that patients with
mild-to-severe COPD could have a better
late preservation of pulmonary function af-
ter lobectomy than healthy patients. As dis-
cussed in a very precise way by the authors,
this fact is related to a general improve-
ment of the airway caliber and elastic recoil
that could be, in its turn, related to relief of
hyperinflation, chest wall mechanics, or
both, even if in the nonemphysematous
lung. In addition, resection of dead space
could have its role.
We would like to briefly comment on
these figures, trying to relate them to the
possible role a pulmonary rehabilitation
(PR) program might have in this kind of
surgical population, and kindly ask for the
authors to disclose their point of view ac-
cording to their experience.
Today there is body of evidence regard-
ing the efficacy of PR in the comprehensive
management of patients with respiratory
disease, and PR programs are practiced
worldwide.2 Positive results in terms of
improvement in dyspnea, exercise capac-
ity, and quality of life are recognized in
chronic obstructive and nonobstructive pul-
monary disease, including COPD, cystic
fibrosis, and restrictive thoracic disease.3,4
Our group has a timely established in-
terest in the issue of PR applied to patients
who have undergone (or are candidates for)
resection for lung cancer, and we have re-
ported evidence that patients who under-
went PR after pulmonary resection demon-
strated a better improvement than those
who, at discharge from the surgical unit,
did not attend any postoperative rehabilita-
tion protocol. In fact, we have reported that
an early postoperative rehabilitative inter-
vention prevents deterioration and speeds
up recovery of function, with direct effects
on ventilatory, gas exchange, and hemody-
namic parameters (work of breathing, lung
compliance, alveolar-arterial difference,
maximum oxygen consumption, arterial
oxygen tension, heart rate, arterial lactate
concentration, cardiac index, and pulmo-
nary artery pressure) and little or no signif-
icant effect on static and dynamic lung
volumes, according to previously outlined
experiences.5 Further analysis (data sub-
mitted for publication) of our experience
supports this evidence. Because it appears
that only patients with mild-to-severe
COPD obtain an improvement in terms of
lung volumes (related to the preoperative
COPD index also)1 from the removal of
lung parenchyma associated with resection
for cancer, we would like the authors to
comment on the fact that a postoperative
rehabilitation program adopted in these pa-
tients could improve ventilatory, hemody-
namic, and gas exchange parameters con-
curring to a better clinical outcome and
quality of life status.
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Reply to the Editor:
We do agree with Cesario and colleagues that
pulmonary rehabilitation (PR) could improve
clinical conditions in patients with chronic
obstructive pulmonary disease (COPD), as
well as in patients operated on for lung can-
cer, although PR in patients with COPD takes
into account different strategies compared
with rehabilitation in surgical patients. In-
deed, PR in patients with COPD, particularly
long-term physical training programs, can
ameliorate dyspnea, exercise capacity, and
quality of life but not pulmonary volumes
and gas exchange.1 On the other hand, pre-
operative and postoperative PR, including
chest physiotherapy, deep-breathing exer-
cises, continuous positive airways pressure,
incentive spirometry and so on, can reduce
respiratory complications and hospital
stay2 by reducing bronchial sputum impac-
tion and bronchial secretions and by alve-
olar recruitment. This approach is com-
monly adopted in most thoracic units and
usually in general operations for high-risk
patients.
In our study we evaluated patients sub-
mitted to lobar or limited lung resection,
taking into account the late postoperative
pulmonary recovery; for this reason, we
have not considered the early functional
outcome and postoperative pulmonary
complications. The pulmonary function
tests and blood gas analysis were per-
formed after hospital discharge (usually be-
tween the 3rd and 15th month), and there-
fore in our study preoperative and
postoperative PR has not been considered
because of its limited role in this context. In
our hospital we perform a short course of
preoperative and postoperative PR (chest
physiotherapy, incentive spirometry, huff-
ing, coughing, and, when necessary, con-
tinuous positive airways pressure) in pa-
tients submitted to lung resection, and this
contributes to reduce postoperative pulmo-
nary complications, but I do not have ex-
perience on the effect on gas exchange and
on hemodynamic and pulmonary function,
although I suspect that this would occur
mainly in patients with excessive bronchial
secretion and postoperative atelectasis.
Reports2,3 emphasize the importance of in-
tensive PR (at least a 2- to 4-week course)
in patients undergoing lung cancer surgery,
and I think that in patients with moderate-
to-severe COPD, this strategy can improve
the outcome of lung resection, especially
considering that these patients seem to
deteriorate less compared with normal
patients.4-8
Sergio Baldi, MD
Enrico Ruffini, MD
Ospedale S. Giovanni Battista, Torino
Respiratory Diseases
3, Via Genova
Torino 10126
Italy
E-mail: baldi_sergio@hotmail.com
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Dor fundoplication after myotomy for
achalasia: Useful, unnecessary, or
harmful?
To the Editor:
We appreciated the interesting and accu-
rate article from Rice and colleagues1
that was recently published in the Jour-
nal. In this report, the authors empha-
sized the fact that addition of a Dor-type
fundoplication procedure to a Heller my-
otomy increases both resting and residual
lower esophageal sphincter (LES) pres-
sure, reducing the adequacy of myotomy
itself. Our group has established experi-
ence with this issue. We reported that the
basal LES pressure, measured by intraop-
erative manometry, was always close to 0
mm Hg after myotomy and increased af-
ter Dor fundoplication.2 On the basis of
our own previous observations, we pre-
sume that pressure values recorded in
patients undergoing myotomy alone re-
main somewhat high because of an un-
derlying incomplete incision of muscular
fibers as the result of technical difficul-
ties (62% of patients in the study by Rice
and colleagues1 had prior nonsurgical
treatments). Furthermore, in the report,1
the addition of a Dor fundoplication in-
creased both resting and residual LES
pressure but did not impair esophageal
emptying. In our experience, higher pres-
sures recorded in the Heller-Dor group
could be easily related to a newly estab-
lished “high pressure zone” rather than to
an inadequate myotomy.
According to this evidence and that
outlined in the prospective, randomized,
double-blind clinical trial by Richards
and colleagues,3 we advise the use of a
partial anterior fundoplication after my-
otomy for several reasons. First, because
the Dor-type procedure does not cause a
significant postoperative dysphagia, and
second, and most important, as also dem-
onstrated by Costantini and colleagues,4
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